MET and FASN as Prognostic Biomarkers of Triple Negative Breast Cancer: A Systematic Evidence Landscape of Clinical Study

BACKGROUND: To know the expression of Mesenchymal–Epithelial Transition factor (MET) and Fatty Acid Synthase (FASN) in Triple Negative Breast Cancer (TNBC) patients, as well as its relationship with clinical pathological characteristic and prognosis. METHODS: we used immunohistochemistry staining to...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Weihua, Xing, Xiao-Liang, Zhang, Chenguang, Yi, Lina, Xu, Wenting, Ou, Jianghua, Zhu, Ning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8190390/
https://www.ncbi.nlm.nih.gov/pubmed/34123778
http://dx.doi.org/10.3389/fonc.2021.604801

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8190390/
https://www.ncbi.nlm.nih.gov/pubmed/34123778
http://dx.doi.org/10.3389/fonc.2021.604801

Ejemplares similares